Friday, July 17, 2026

11:15 AM - 1:15 PM

---

Overview

Provisional

---

Details

Epilepsy is a common brain disease,characterized by transient but recurrent seizures accompanied with abnormal synchronous neuronal activity in the brain,. Anti-seizure drugs are the mainstay of the management of epilepsy for patients, but often less effective. The mechanism of epilepsy is still not well understood. It is considered to be a complex syndrome pathologically involved in the neural circuit/ cellular / molecular multiple-level dysfunction. Our sumposium will includes substantial progress in the field of epilepsy relevant to preclinical and clinical epilepsy research, such as the finding of new epileptogenetic genes, development of new drug targets, novel optogentic or chemogenetic approaches control of epileptic seizure, neural circuit mechanism of epilepsy based on multiple-channels EEG recording and imaging, the updated clinical epilepsy definition, and so on. All of these would be very important to improve management of the epilepsies in the future and be of interest to the broad international pharmacology community.

---

Session chair